Impedance monitoring for detecting pulmonary edema and thoracic congestion

• US 7,313,434 B2
• Filed: 11/25/2002
• Issued: 12/25/2007
• Est. Priority Date: 11/25/2002
• Status: Active Grant

• Current Assignee: Regents of The University of Minnesota (University of Minnesota)
• Original Assignee: Regents of The University of Minnesota (University of Minnesota)
• Inventors: Belalcazar, Andres, Patterson, Robert, Shult, Rebecca
• Primary Examiner(s): Hindenburg, Max F.
• Assistant Examiner(s): Apanius, Michael
• Application Number:
  US10/303,305
• Publication Number:
  US 20040102712A1
• Time in Patent Office: 1,856 Days
• Field of Search: 600/508, 600/529, 600/547, 607 4- 6, 607/9
• US Class Current: 600/547
• CPC Class Codes: A61B 5/053 Measuring electrical impedance or conductance of a portion of the body
• CPC Class Codes: A61B 5/4869 Determining body composition
• CPC Class Codes: A61B 5/4878 Evaluating oedema

Abstract

An implantable medical device includes a housing for the implantable device that is sized for implantation in a chest region of a patient and includes a housing electrode. A left ventricular lead port is connectable to a proximal end of a lead having first and second insulated conductors that extend from the proximal end of the lead to corresponding first and second electrodes near a distal end of the lead. An electrical impedance measurement circuit is electrically connected to the left ventricular lead port and the housing electrode. The circuit may inject current between the first lead electrode and the housing electrode, and measure a voltage potential, created by the current injection, between the second lead electrode and the housing electrode. The ratio of the measured voltage to injected current may be used for assessing pulmonary edema. The lead electrodes may be located in a left ventricular coronary vein.

Claims

1. A method of monitoring pulmonary edema in a human being, the method comprising:

injecting an electrical current between a first electrode located in a coronary vein of a left ventricle and a housing of a medical device implanted in a chest region;

measuring a voltage potential between a second electrode located in the coronary vein of the left ventricle and the medical device housing; and

assessing pulmonary edema based on an impedance value calculated from the electrical current and the voltage potential and a stored edema threshold impedance value.

2. The method of claim 1 further comprising calculating an impedance value by taking a ratio of the measured voltage potential to the injected current.

3. A method of monitoring pulmonary edema in a human being, the method comprising:

injecting a first electrical current between a first electrode located in a coronary vein of a left ventricle and a housing of a medical device implanted in a chest region;

measuring a first voltage potential between a second electrode located in the coronary vein of the left ventricle and the medical device housing, the first voltage potential created by the first current injection;

injecting a second electrical current between a third electrode located in a right atrium and the medical device housing;

measuring a second voltage potential between a fourth electrode located in the right atrium and the medical device housing, the second voltage potential created by the second current injection; and

assessing pulmonary edema based on an impedance value calculated from the electrical currents and the voltage potentials and a stored edema threshold impedance value.

4. The method of claim 3 further comprising:

calculating a first impedance value by taking a first ratio of the measured first voltage potential to the injected first current; and

calculating a second impedance value by taking a second ratio of the measured second voltage potential to the injected second current.

5. The method of claim 4 wherein a weighted combination of the first and second impedance values is used to assess pulmonary edema.